Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

COGTCOGT
Showing 8 of 23 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in Cogent Biosciences, Inc.

GEODE CAPITAL MANAGEMENT, LLC holds 4.5M shares of COGT (Cogent Biosciences, Inc.), worth $174.5M as of 2026-Q2. The position was increased (+21.9% shares). COGT represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$174.5M

Current Shares

4.5M

Total Value Change

+$149.9M

Total Shares Change

+2.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.5M
+21.9%
$174.5M0.0%$38.70
37
2026-Q1
Increased
3.7M
+5.3%
$142.4M0.0%$37.24
32
2025-Q4
Increased
3.5M
+7.3%
$124.9M0.0%$37.12
32
2025-Q3
Increased
3.3M
+22.5%
$47M0.0%$14.13
35
2025-Q2
Increased
2.7M
+10.6%
$19.2M0.0%$7.10
31
2025-Q1
Increased
2.4M
+4.7%
$14.5M0.0%$6.48
29
2024-Q4
Increased
2.3M
+1.2%
$18M0.0%$7.71
29
2024-Q3
Increased
2.3M
+15.2%
$24.6M0.0%$10.90
33

Other major holders of COGT: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used